Attached files

file filename
EX-99.1 - Intellect Neurosciences, Inc.v200114_ex99-1.htm
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): October 27, 2010
 
Intellect Neurosciences, Inc.
(Exact Name Of Registrant As Specified In Its Charter)

Delaware
(State or Other Jurisdiction of Incorporation)
 
333-128226
20-2777006
(Commission File Number)
(I.R.S. Employer Identification No.)
   
45 West 36th Street, New York, NY
10018
(Address of Principal Executive Offices)
(Zip Code)
 
(212) 448-9300
(Registrant’s Telephone Number, Including Area Code)

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 

 
Item 8.01. Other Events.
 
On October 27, 2010, Intellect Neurosciences, Inc. (OTCBB: ILNS) and two of its significant shareholders executed a non-binding letter of intent containing the material terms of proposed additional funding to be provided by such shareholders to Intellect. The contemplated transactions are subject to negotiation and execution of definitive agreements and there can be no assurance that the transaction will be consummated.  A copy of the letter of intent is attached hereto as Exhibit 99.1 and is incorporated herein in its entirety by reference.
 
Item 9.01 Financial Statements and Exhibits.
 
(d) Exhibits.
 
The following exhibit is furnished as part of this Report on Form 8-K:
 
Exhibit Description
 
99.1           Letter of Intent dated October 27, 2010
 
..
 
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
     
 
INTELLECT NEUROSCIENCES, INC.
     
Date: October 27, 2010
By:  
/s/ Elliot Maza
 
Name: Elliot Maza
 
Title: President and CFO